Check out the new Prime/MRx GLP-1 Strategy page

March 14, 2024

After the release of its industry-leading research on GLP-1a drugs for weight loss in July 2023, Prime Therapeutics/Magellan Rx Management (Prime/MRx) continues to shape the narrative on this dynamic trend.

We’ve compiled all of our GLP-1 resources and thought leadership onto a new GLP-1 Strategy page, including our research, podcasts, videos, recent articles and more. Our aim is to highlight our evidence-based approach to GLP-1 drugs, working with our partners to develop individualized strategies that promote clinically appropriate use and consider total cost of care, long-term value, and member health outcomes.

For more, check back for regular updates on our Prime News site.

And to get the latest news and insights from Prime/MRx, sign-up for our twice-a-month newsletter, Prime Post.

Related news

Perspectives

April 19, 2024

AMCP 2024: Behind the Research with Prerak Parikh

Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars

Perspectives

April 19, 2024

LISTEN NOW: Live at AMCP Annual 2024 – Digging into managed care pharmacy insights | Pharmacy Friends podcast

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans

Perspectives

April 17, 2024

AMCP 2024: Behind the research with YuQian Liu

Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of this exciting frontier